CLINICAL_TRIALS ClinicalTrials.gov record update

Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid (5-ALA) vs. Conventional Resection

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00241670
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:20.195298+00:00
Published At: 2012-04-26T00:00:00+00:00
Record Updated At: 2012-04-26
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Brain Cancer", "Brain Tumors", "Cancer of Brain", "Primary Brain Tumors", "Brain Tumor, Primary"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2012-04-26"
protocolSection.identificationModule.nctId: "NCT00241670"
protocolSection.identificationModule.officialTitle: "Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid (5-ALA) vs. Conventional Resection"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.